Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Antía Cousillas"'
Autor:
Ana Fernández Montes, Alberto Carmona-Bayonas, Paula Jimenez-Fonseca, Francisca Vázquez Rivera, Nieves Martinez Lago, Marta Covela Rúa, Antía Cousillas Castiñeiras, Paula Gonzalez Villarroel, Juan De la Cámara Gómez, José Carlos Méndez Méndez, Carmen Carriles Fernández, Manuel Sanchez Cánovas, Teresa Garcia García
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Trifluridine/tipiracil increases overall survival (OS) in patients with refractory, metastatic colorectal cancer (mCRC). A post hoc exploratory analysis of the RECOURSE randomized clinical trial (RCT) established two categories, a good progn
Externí odkaz:
https://doaj.org/article/79955248229f4b8ab9ff4d86bc53b994
Autor:
Nieves Martínez-Lago, Ana Fernández-Montes, Marta Covela, Elena M. Brozos, Juan De la Cámara, José C. Méndez Méndez, Mónica Jorge-Fernández, Antía Cousillas Castiñeiras, Cristina Reboredo, David Arias Ron, María L. Pellón Augusto, Paula González Villarroel, Begoña Graña, Mercedes Salgado Fernández, Alberto Carral Maseda, Francisca Vázquez Rivera, Sonia Candamio Folgar, Margarita Reboredo López, On behalf of the Galician Research Group on Digestive Tumors (GITuD)
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Outcomes are poorer in metastatic colorectal cancer (mCRC) patients with BRAF V600E mutations than those without it, but the effect of these mutations on treatment response is unclear. This real-world study assessed the effects of
Externí odkaz:
https://doaj.org/article/0205a0ed5fdf486f96be2430c7159205
Autor:
Nieves Martínez-Lago, Soledad Cameselle García, Beatriz Alonso de Castro, Martín I. Gómez-Randulfe Rodríguez, Marta Carmona Campos, Paula González Villarroel, Mercedes Salgado Fernández, Juan C. De la Cámara Gómez, Carlos Romero Reinoso, Antía Cousillas Castiñeiras, José Carlos Méndez Méndez, Yolanda Vidal Insua, Ana Fernández-Montes
Publikováno v:
PLoS ONE, Vol 17, Iss 6 (2022)
Background The VELOUR study showed the benefit of FOLFIRI-Aflibercept (FA) versus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in second-line treatment. However, only 36% of the included patients were ≥65 years. Thus, we seek to eva
Externí odkaz:
https://doaj.org/article/e00901a0b5b7464ca871c78422a4ada3
Autor:
Ana Fernández Montes, Nieves Martinez-Lago, Juan de la Cámara Gomez, Elena María Brozos Vázquez, Sonia Candamio Folgar, Marta Carmona Campos, Antía Cousillas Castiñeiras, Marta Covela Rúa, Elena Gallardo Martín, Paula González Villarroel, Begoña Graña Suarez, Mónica Jorge Fernández, María Luz Pellón Augusto, Guillermo Quintero Aldana, Carlos Romero Reinoso, Mercedes Salgado Fernández, Francisca Vázquez Rivera, Ana Ayuso Álvarez, Dante R. Culqui, José Carlos Méndez Méndez, RIGhT-sens Working Group
Publikováno v:
Healthcare, Vol 9, Iss 6, p 665 (2021)
Background: In recent years, abundant scientific evidence has been generated based on clinical trials (CT) in the field of oncology. The general objective of this paper is to find out the extent to which decision making is based on knowledge of the m
Externí odkaz:
https://doaj.org/article/01792a8c5c8744f0a15982e2682a7257
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
T. García, Juan de la Cámara Gómez, Alberto Carmona-Bayonas, Marta Covela Rúa, Francisca Vázquez Rivera, Paula Jiménez-Fonseca, Manuel Cánovas, Ana Montes, Carmen Carriles Fernández, Paula Gonzalez Villarroel, Nieves Martinez Lago, Antía Cousillas Castiñeiras, J. Méndez
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
Scientific Reports
Trifluridine/tipiracil increases overall survival (OS) in patients with refractory, metastatic colorectal cancer (mCRC). A post hoc exploratory analysis of the RECOURSE randomized clinical trial (RCT) established two categories, a good prognosis corr
Publikováno v:
Translational Cancer Research
Gastric adenocarcinoma arises after a complex interaction between the host and environmental factors. Tumor location and TNM are the tools that currently guide treatment decisions. Surgery is the only curative treatment, but relapse is common. After
Autor:
Pablo Pérez-Galindo, Jose Manuel Benítez, Cristina Rubín de Célix, Francisco Mesonero, Andrés Castaño García, Maria José García, Miren Vicuña, Lorena Bernal, Federico Bertoletti, Cynthia Ramírez Castro, María Sánchez-Azofra, Laura Sánchez-Delgado, Ángel Ponferrada, Coral Tejido Sandoval, María Capilla, Viviana Laredo de la Torre, Maria Teresa Diz-Lois, Carmen Dueñas Sadornil, Natalia García-Morales, María González-Vivo, Beatriz López-Cauce, Luigi Melcarne, Cristina Calviño- Suárez, Esteban Lastiri González, Patricia Ramírez de la Piscina, Antía Cousillas, JP Gisbert, Isabel Pérez-Martínez, Beatriz Castro, Miriam Mañosa, Daniel Carpio, Manuel Barreiro-de Acosta
Publikováno v:
Gastroenterología y Hepatología. 46:S77
Autor:
Nieves Martínez-Lago, Soledad Cameselle García, Beatriz Alonso de Castro, Martín I. Gómez-Randulfe Rodríguez, Marta Carmona Campos, Paula González Villarroel, Mercedes Salgado Fernández, Juan C. De la Cámara Gómez, Carlos Romero Reinoso, Antía Cousillas Castiñeiras, José Carlos Méndez Méndez, Yolanda Vidal Insua, Ana Fernández-Montes
Publikováno v:
PloS one. 17(6)
Background The VELOUR study showed the benefit of FOLFIRI-Aflibercept (FA) versus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in second-line treatment. However, only 36% of the included patients were ≥65 years. Thus, we seek to eva
Autor:
Montes, Ana Fernández, Martinez-Lago, Nieves, Gomez, Juan de la Cámara, Vázquez, Elena María Brozos, Folgar, Sonia Candamio, Campos, Marta Carmona, Castiñeiras, Antía Cousillas, Rúa, Marta Covela, Martín, Elena Gallardo, Villarroel, Paula González, Suarez, Begoña Graña, Fernández, Mónica Jorge, Augusto, María Luz Pellón, Aldana, Guillermo Quintero, Reinoso, Carlos Romero, Fernández, Mercedes Salgado, Rivera, Francisca Vázquez, Álvarez, Ana Ayuso, Culqui, Dante R., Méndez, José Carlos Méndez, Group, RIGhT-sens Working Group RIGhT-sens Working
Publikováno v:
Healthcare
Volume 9
Issue 6
Healthcare, Vol 9, Iss 665, p 665 (2021)
Repisalud
Instituto de Salud Carlos III (ISCIII)
Volume 9
Issue 6
Healthcare, Vol 9, Iss 665, p 665 (2021)
Repisalud
Instituto de Salud Carlos III (ISCIII)
Background: In recent years, abundant scientific evidence has been generated based on clinical trials (CT) in the field of oncology. In spite of this, there are still major disagreements among the group when it comes to establishing a treatment and t